AARP
According to a recent Reuters article, AARP is urging a federal judge not to block a new law that empowers Medicare to negotiate drug prices with pharma companies. The call comes in response to a lawsuit filed by business groups seeking to halt negotiations. AARP argues that stopping the drug price negotiation program would hinder Congress' goal of lowering drug prices and harm older Americans, emphasizing that Medicare recipients have an average income of less than $30,000 per year.
